CD8A and neoplasm: These findings prompted us to assess whether ISIM facilitated priming of tumor-specific CD8+ T cells using a tetramer (Tet) to identify H-2Ld-restricted MuLV gp70-specific CD8+ T cells in mice bearing 4T1 tumor, which harbor gp70 epitopes as an endogenous TAA25.